Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancer

Approximately, 25–30% of early-stage breast tumors are classified at the molecular level as HER2-positive, which is an aggressive subtype of breast cancer. Amplification of the HER2 gene in these tumors results in a substantial increase in HER2 mRNA levels, and consequently, HER2 protein levels. HER...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Merry, Callie R., McMahon, Sarah, Forrest, Megan E., Bartels, Cynthia F., Saiakhova, Alina, Bartel, Courtney A., Scacheri, Peter C., Thompson, Cheryl L., Jackson, Mark W., Harris, Lyndsay N., Khalil, Ahmad M.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5288181/
https://ncbi.nlm.nih.gov/pubmed/27449296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10637
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados